Superantigen-mediated cellular cytotoxicity is dependent on antigen expression, but independent of the P-glycoprotein multidrug resistance phenotype

被引:3
作者
Zehrer, C
Beck, J
Gekeler, V
Ihle, J
Holzer, U
Dohlsten, M
Kalland, T
Niethammer, D
Dannecker, GE
机构
[1] CHILDRENS UNIV HOSP,DEPT HAEMATOL & ONCOL,D-72070 TUBINGEN,GERMANY
[2] BYK GULDEN LOMBERG GMBH,D-7750 CONSTANCE,GERMANY
[3] PHARMACIA ONCOL IMMUNOL,LUND,SWEDEN
关键词
multidrug resistance; P-glycoprotein; monoclonal antibodies; cytotoxic T cells; superantigen;
D O I
10.1046/j.1365-2141.1996.d01-1938.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Superantigen-activated T cells can be targeted by monoclonal antibodies (mAb) to lyse MHC class II negative tumour cells. In this study we determined the susceptibility of the T-lymphoblastoid leukaemic cell line CCRF-CEM and its multidrug resistant sublines CCRF VCR100, CCRF VCR1000 and CCRF ADR5000 to lysis by monoclonal antibody-targeted and superantigen-activated T cells (superantigen-dependent cellular cytotoxicity, SDCC), A recombinant fusion protein of protein A and the superantigen Staphylococcus enterotoxin A (SEA) was used together with the mAbs anti-CD7, anti-CD38, anti-CD45RA and 4E3 (anti-P-glycoprotein) to correlate susceptibility to SDCC with expression of the MDR1-gene product, Our results demonstrated SDCC to be independent of MDR1-gene expression. This was further confirmed by blocking the function of Pgp in the leukaemic cell lines with a cyclosporine A derivative, which had no influence on SDCC. As expected, expression of the respective cell surface antigens on target cells had a strong impact on SDCC, although other factors seem to influence efficiency of SDCC as well.
引用
收藏
页码:452 / 456
页数:5
相关论文
共 18 条
[1]   CHARACTERIZATION OF 2 DISTINCT MHC CLASS-II BINDING-SITES IN THE SUPERANTIGEN STAPHYLOCOCCAL-ENTEROTOXIN-A [J].
ABRAHMSEN, L ;
DOHLSTEN, M ;
SEGREN, S ;
BJORK, P ;
JONSSON, E ;
KALLAND, T .
EMBO JOURNAL, 1995, 14 (13) :2978-2986
[2]  
ARCECI RJ, 1993, CANCER RES, V53, P310
[3]   EXPRESSION OF MDR1, MRP, TOPOISOMERASE-II-ALPHA/BETA, AND CYCLIN-A IN PRIMARY OR RELAPSED STATES OF ACUTE LYMPHOBLASTIC LEUKEMIAS [J].
BECK, J ;
HANDGRETINGER, R ;
DOPFER, R ;
KLINGEBIEL, T ;
NIETHAMMER, D ;
GEKELER, V .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (02) :356-363
[4]  
BOESCH D, 1991, CANCER RES, V51, P4226
[5]   MULTIDRUG-RESISTANCE IN PEDIATRIC MALIGNANCIES [J].
CHAN, HSL ;
DEBOER, G ;
HADDAD, G ;
GALLIE, BL ;
LING, V .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1995, 9 (02) :275-318
[6]   EXPRESSION AND ACTIVITY OF P-GLYCOPROTEIN, A MULTIDRUG EFFLUX PUMP, IN HUMAN HEMATOPOIETIC STEM-CELLS [J].
CHAUDHARY, PM ;
RONINSON, IB .
CELL, 1991, 66 (01) :85-94
[7]   ANTIBODY-TARGETED SUPERANTIGENS ARE POTENT INDUCERS OF TUMOR-INFILTRATING T-LYMPHOCYTES IN-VIVO [J].
DOHLSTEN, M ;
HANSSON, J ;
OHLSSON, L ;
LITTON, M ;
KALLAND, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (21) :9791-9795
[8]  
DOHLSTEN M, 1990, IMMUNOLOGY, V71, P96
[9]   MDR1/P-GLYCOPROTEIN, TOPOISOMERASE, AND GLUTATHIONE-S-TRANSFERASE-PI GENE-EXPRESSION IN PRIMARY AND RELAPSED STATE ADULT AND CHILDHOOD LEUKEMIAS [J].
GEKELER, V ;
FRESE, G ;
NOLLER, A ;
HANDGRETINGER, R ;
WILISCH, A ;
SCHMIDT, H ;
MULLER, CP ;
DOPFER, R ;
KLINGEBIEL, T ;
DIDDENS, H ;
PROBST, H ;
NIETHAMMER, D .
BRITISH JOURNAL OF CANCER, 1992, 66 (03) :507-517
[10]   BIOCHEMISTRY OF MULTIDRUG-RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER [J].
GOTTESMAN, MM ;
PASTAN, I .
ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :385-427